AzTrials
AzTrials

Performance EnhancementNCT04155333

Effects of Non-Invasive Brain Stimulation on Soldiers' Cognitive and Functional Performance

A study testing Transcranial direct current stimulation in people with Performance Enhancement, run by United States Army Aeromedical Research Laboratory at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Non-invasive brain stimulation has been shown to alter performance in both clinical and healthy populations on cognitive tasks. While the performance alterations have generally been shown to result in enhancement, mixed results remain in the literature. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Performance Enhancement
What is being tested?
Transcranial direct current stimulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
28 participants
Where
1 siteUnited States
Study dates
12 Dec 2019to 30 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Must be 18 (if active duty), 19 (if non-active duty) up to 40 years old.
  • Must have normal hearing, vision or corrected to normal vision, and cognitive function as determined by self-report and screening by study physician
  • Must have obtained at minimum 6 hours of sleep prior to data collection, as assessed by actigraphy data and self-report.
  • Must have refrained from consumption of caffeine, 16 hours, nicotine, 2 hours, and alcohol, 24 hours, prior to the study, assessed by self-report.

Who cannot join

  • The following medically-related exclusionary criteria will be used, as assessed and verified by the study physician:
  • Haven taken any medications which induce drowsiness, such as over-the-counter antihistamines within 24 hours of participation in the study. Any self-medication will be assessed through self-report
  • No current medical conditions or medications affecting cognitive function or attention.
  • Any history of any attention deficit condition requiring medication.
  • Any history of psychological/psychiatric disorder.
  • Any history of seizures, migraines, or neurological disorders.
Show all 12Show fewer
  • History of a head injury involving loss of consciousness.
  • Any metal implanted within the head (e.g., shrapnel, surgical clips) or any implanted devices (e.g., cardiac pacemaker, brain stimulator, hydrocephalic shunt).
  • Skin condition on the scalp, such as psoriasis or eczema, or wounds on the head.
  • Currently receiving hormonal therapy treatments, other than birth control or as determined by physicians.
  • Potential for caffeine withdrawal symptoms that will impede cognitive testing.
  • Females with a known pregnancy, who test positively for pregnancy, or refuse the test will be excluded, given the lack of available research regarding the effects of tDCS during pregnancy. Known pregnancy will be assessed during screening, females without a known pregnancy will be requested to provide a urine sample during the screening procedures to ensure the absence of pregnancy.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • U.S. Army Aeromedical Research Laboratory

    Fort Rucker, Alabama, 36362

Other trials in United States

About this study

Non-invasive brain stimulation has been shown to alter performance in both clinical and healthy populations on cognitive tasks. While the performance alterations have generally been shown to result in enhancement, mixed results remain in the literature. Much of the mixed results within the literature have been attributed to the use of different stimulation parameters, targeting of different brain areas, and using a variety of performance measures or assessing different constructs. However, non-invasive brain stimulation is a desirable method for enhancing Soldier performance given the ease of administration and minimal side effects as compared to other forms of performance enhancement (e.g., pharmaceuticals, caffeine). The objective of the current study is to evaluate the effects of non-invasive brain stimulation to the left dorsolateral prefrontal cortex in enhancing Soldier cognitive skills and performance on military tasks. A double blind within-subjects design will be used with healthy, rested Soldiers who will receive non-invasive brain stimulation and perform basic cognitive and operationally relevant tasks.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial direct current stimulationDevice

    Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation that stimulates the brain through the application of a low-intensity electrical current, typically ranging from 1 to 2 milliamps (mA), via electrodes placed on an individual's scalp. During the active stimulation sessions, 2 mA of stimulation will be applied for 30 minutes. During the sham stimulation session, 2 mA of stimulation will be applied over the course of 90 sec, the electrodes will remain in place for the 30 minute duration.

Study groups in NCT04155333
Study groupRoleWhat they receive
Active anodal stimulationExperimentalactive anodal stimulation at F3, cathode placed on contralateral bicep
Receives: Device: Transcranial direct current stimulation
Active cathodal stimulationExperimentalactive cathodal stimulation at F3, anode placed on contralateral bicep
Receives: Device: Transcranial direct current stimulation
Sham stimulationSham comparatorsham stimulation that will be counterbalanced between subjects such that half will receive sham stimulation configured as condition 1 (anode F3, cathode bicep) and half will receive condition 2 (cathode F3, anode bicep)
Receives: Device: Transcranial direct current stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Military task performance

    Patrol exertion multitask

    Measured: Folllowing stimulation; task lasts approximately 20 min

  2. Military task performance

    Target acquisition

    Measured: Folllowing stimulation; task lasts approximately 40 min

  3. Cognitive function - Selective Attention

    Stroop test

    Measured: Approximately 3 minutes during stimulation

  4. Cognitive function - Multitasking/Working Memory

    Dual n-back

    Measured: Approximately 5 minutes during stimulation

  5. Cognitive function - Working Memory

    Digit span task

    Measured: Approximately 2 minutes during stimulation

  6. Cognitive function - Sustained attention

    Rapid Visual Information Processing Task

    Measured: Approximately 7 minutes during stimulation

  7. Cognitive function - Executive function

    Shifting Attention Task: Digit symbol substitution task

    Measured: Approximately 2 minutes during stimulation

Secondary outcomes (3)
  1. Cognitive function - Impulsivity/Motor Control

    Stop signal task - response inhibition

    Measured: Approximately 3 minutes after stimulation

  2. Cognitive function - Risk Taking/ Decision Making

    Delayed Discounting Task

    Measured: Approximately 1 minute after stimulation

  3. Cognitive function - Cognitive Flexibility

    Uses Task

    Measured: Approximately 5 minutes after stimulation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2019
  2. Study start12 Dec 2019
  3. Primary completion1 Jun 2021
  4. Study completion30 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
A double-blind, randomized, sham-controlled, within-subjects design
Masking
Single blind
Who is masked
Investigator
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04155333
Sponsor's protocol ID
USAARL 2018-002; M-10782
Status last verified
Jan 2022
First submitted
5 Nov 2019
Last updated
25 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Transcranial direct current stimulation in people with Performance Enhancement, run by United States Army Aeromedical Research Laboratory at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Military task performance (time frame: Folllowing stimulation; task lasts approximately 20 min). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in